Impact of Baseline Neuropathy Severity on Vutrisiran Treatment Response in the Phase 3 HELIOS-A Study

Luigetti, MarcoMarcoLuigettiQuan, DiannaDiannaQuanBerk, John LJohn LBerkConceição, IsabelIsabelConceiçãoMisumi, YoheiYoheiMisumiCHI-CHAO CHAOBender, ShaunShaunBenderAldinc, EmreEmreAldincVest, JohnJohnVestAdams, DavidDavidAdams2026-03-162026-03-162024-06https://scholars.lib.ntu.edu.tw/handle/123456789/736398enATTRv amyloidosisBaseline NIS quartilesDisabilityNeuropathy severityNutritional statusPolyneuropathyQuality of lifeRNA interferenceVutrisiranImpact of Baseline Neuropathy Severity on Vutrisiran Treatment Response in the Phase 3 HELIOS-A Studyjournal article10.1007/s40120-024-00595-938512694